Integra Enters Shoulder Market, Builds Upper Extremity Biz Via Ascension Purchase
This article was originally published in The Gray Sheet
Executive Summary
Integra LifeSciences will expand its orthopedic extremity implant offerings and bolster its upper extremity business in particular while entering the shoulder market for the first time with its $65 million acquisition of Ascension Orthopedics, announced Sept. 12.